Back Stocks profile

Stock analysis tool for investors

Procter & Gamble Health Ltd.

NSE: PGHL | BSE:500126

₹4995.00 -9.20 (-0.18%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

4963.00

Today’s High

5050.00

52W low

4636.60

52W High

5642.80

Open Price

4996.00

Prev. Close

4935.5500

Volume

7203.00

Value

35978985.00

Fundamentals

Market Cap Cr

8291.40

Price to Earnings

38.70

Price to Book Value

11.00

Dividend Yield

5.00

PE to Growth

-3.50

Op Revenue TTM Cr

1168.56

Net Profit TTM Cr

214.02

Cash From Operating Activity Cr

236.00

Return on Equity %

30.55

EMA & SMA

Bullish Moving Averages

13

Bearish Moving Averages

3

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Jun, 2024

77

Week

66

Month

64.9

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5001.03

PIVOT

First Resistance

5043.07

Second Resistance

5081.93

Third Resistance

5123.97

First Support

4962.17

Second Support

4920.13

Third Support

4881.27

Relative Strength Index

60.11

Money Flow Index

69.91

MACD

63.42

MACD Signal

49.14

Average True Range

112.72

Average Directional Index

23.34

Rate of Change (21)

3.61

Rate of Change (125)

-1.17

Commodity Channel Index

74.3

Williams %R

-28.6

BETA

1 Month

0.14

3 Month

0.23

1 Year

0.19

3 Year

0.19

PRICE CHANGE ANALYSIS

0.71%

1 Week

Low

High

4922.95

5150

3.42%

1 Month

Low

High

4641.15

5150

2.56%

3 Months

Low

High

4636.55

5150

-0.17%

6 Months

Low

High

4636.55

5642.85

-1.83%

1 Year

Low

High

4636.55

5642.85

Bigul
12 Jun 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

There has been a typographical error in the share certificate details mentioned in the earlier announcement of even date, in this regard find enclosed revised details with respect to loss of share certificates of shareholders of the Company as intimated by the RTA, Kfin technologies Limited.
Bigul
12 Jun 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Ltd.
Bigul
06 May 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, Please be informed that we have issued duplicate share certificate to our shareholder as per attached letter. Kindly take the same on record.
Bigul
03 May 2024

Q3FY24 Quarterly Result Announced for Procter & Gamble Health Ltd.

Pharmaceuticals company Procter & Gamble Health announced Q3FY24 results: Financial Highlights: Procter & Gamble Health Limited reported a decrease in sales and profit after tax for the Q3FY24. The total sales for the quarter were Rs 248 crore compared to Rs 316 crore a year ago, marking a downturn. Correspondingly, the Profit After Tax (PAT) also declined by 21% to Rs 46 crore. For the nine-month period ending March 31, 2024, P&G; Health's sales were recorded at Rs 852 crore, which exhibited a slight reduction from the previous year's sales of Rs 913 crore. The PAT for the nine-month period stood at 184 crore, experiencing a decrease from the Rs 200 crore reported in the prior year. Milind Thatte, Managing Director, P&G; Health India, said, “The Company’s continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter’s sales owing to the transition and optimization of trade management and inventory. However, we have seen sales recover in the months of March and April. We continue to drive operational efficiency and explore innovative solutions to accelerate category growth and demand for our portfolio of trusted, quality healthcare brands. The quarter also witnessed prescription growth and share gain for our doctor detailed products indicating a robust demand, and increased efforts to improve awareness of our self-select products. We remain confident in our integrated growth strategy of a focused product portfolio where performance drives brand choice, superiority, productivity, constructive disruption, and an agile and accountable organization structure to help drive growth and value creation,”he added. Result PDF
Bigul
02 May 2024

Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Find enclosed press release on the unaudited financial results for the quarter ended March 31,2024
Bigul
02 May 2024

Procter & Gamble Health Ltd - 500126 - Quarter Ended March 31,2024

Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 and the limited review report of the auditors thereon.
Bigul
02 May 2024

Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31,2024

Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 along with the limited review report of the auditors thereon.
Bigul
26 Apr 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company
Bigul
19 Apr 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter. Kindly take note of the same.
Bigul
17 Apr 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
See all News

FAQs

The latest market price of Procter & Gamble Health Ltd. on NSE was Rs. 4995.00 as of today.

The opening share price of Procter & Gamble Health Ltd. was Rs. 4996.00 as of today.

The 52-week high share price of Procter & Gamble Health Ltd. was Rs. 5642.80.

The 52 week low share price of Procter & Gamble Health Ltd. was Rs. 4636.60.

Procter & Gamble Health Ltd. has a market cap of Rs. 8291.40 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Procter & Gamble Health Ltd. is -3.50. Please refer to the Fundamentals section for further details.

The operating revenue for Procter & Gamble Health Ltd. in the last FY was Rs.  1168.56 crore. Please refer to the Financials section for further details.

The Net Profit for Procter & Gamble Health Ltd. in the last FY was Rs. 214.02 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Procter & Gamble Health Ltd. was on 2024-02-14 for Rs. 150 per share. According to today’s share price, the dividend yield of Procter & Gamble Health Ltd. stands at 5.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Procter & Gamble Health Ltd..

Close

Let's Open Free Demat Account